Patrick Campbell

Ajay Kuriyan, MD, discusses what he warns patients to be aware of when seeking out treatment from stem cell therapies and why he believes other physicians should as well.

LADDER study results presented at ASRS revealed efficacy of the PDS was equal to that of monthly ranibizumab.

An oral therapy for aged-related macular degeneration could be on the horizon after displaying efficacy in a recent phase 2 study.

Carl Regillo, MD, who presented 96-week data of brolucizumab at ASRS 2019, discusses how brolucizumab could impact care of wAMD in a real-world setting.

More patients undergoing long-term use anti-VEGF therapy saw improvements in visual acuity than saw declines after 10 years.

Investigators from Wills Eye and Retina Consultants of Austin presented 96-week data from the HAWK and HARRIER trials at ASRS 2019.

Peter Kaiser, MD, presented data from a phase 2 trial examining the safety and efficacy of risuteganib at ASRS 2019.

W. Lloyd Clark, MD, discusses the approaches he uses in his clinical practice to reduce patient noncompliance — specifically, when treating diabetic macular edema.

As physician burnout becomes a more common issue, physician across an array of fields find themselves discussing and formulating ways to circumvent burnout.

Physician from Palmetto Retina Center on deciding between aflibercept, ranibizumab, and avastin for treatment of DME.

A recent study published in the journal of the European Journal of Endocrinology found significant benefits of vitamin D supplementation on the development and progression of diabetes.

Investigators examining more than 1000 university students found that those using a smartphone more than 5 hours per day had a 43% increased risk of obesity.

Investigators from Brigham and Women's Hospital found no difference in mortality rate among procedures, even those that coincide with the start of resident training.

With approval, Baqsimi, which was approved for adults and children as young as 4, becomes the first approved treatment of hypoglycemia that can be administered without an injection.

In a recent study, investigators from Johns Hopkins found that risks of peripheral artery disease remains elevated for 30 years after smoking cessation.

Results of the SHINE trial show no significant difference between standard and intensive treatment of hyperglycemia on functional outcomes following acute ischemic stroke.

A recent study has found that the cost and accessibility of PCSK9 inhibitors has created problems for patients seeking an effective treatment for their hypercholesterolemia.

Investigators from the University of Duke School of Medicine compared results of the PROSPER Study and found results supporting the use of DOACs over warfarin in older patients following ischemic stroke.

From vaping to air pollution, Deepak Bhatt, MD, shares his thoughts on the greatest threats to cardiovascular health.

A recent study of more than 12 million people from 10 countries found that the risk of heart failure associated with diabetes was greater in women than in men. 



Deepak Bhatt, MD, executive director of Interventional Cardiovascular Programs at Brigham and Women's Hospital and professor of medicine at Harvard Medical School, discusses potential forthcoming advances in cardiology that excite him most.

A recent study of more than 200,000 injured workers identified risk factors of opioid use of a previously opioid-free population.

A new study has found that both systolic and diastolic blood pressure independently influenced the risk of adverse cardiovascular events.

A recent analysis of the IMPROVE-IT results found that simvastatin-ezetimibe was associated with greater reductions in LDL-C and lower rates of MI, stroke and CVD than simvastatin monotherapy.

Merck announced the FDA's approval of their NDA for imipenem, cilastatin, and relebactam (Recarbrio) on Wednesday morning.

Study from investigators in London found that high iron levels were associated with a lower risk of high cholesterol levels and reductions in atherosclerosis, but these same high levels were also associated with increased risk of stroke.

Investigators comparing New York and a group of control states before and after mandates found greater than expected reductions of in-hospital mortality.

Recent study shows that obesity appears to be associated with an increased pediatric MS risk and that obese patients did not respond well to first-line medications.

Investigators examined more than 3500 adolescents and found associations between computer and social media use, but not video game and television use.

Professor of medicine at Harvard Medical School discusses how much progress has been made in the fight against cardiovascular disease.